Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Complete Versus Lesion-Only Primary PCI: The Randomized Cardiovascular MR CvLPRIT Substudy.
McCann GP, Khan JN, Greenwood JP, Nazir S, Dalby M, Curzen N, Hetherington S, Kelly DJ, Blackman DJ, Ring A, Peebles C, Wong J, Sasikaran T, Flather M, Swanton H, Gershlick AH. McCann GP, et al. Among authors: khan jn. J Am Coll Cardiol. 2015 Dec 22;66(24):2713-2724. doi: 10.1016/j.jacc.2015.09.099. J Am Coll Cardiol. 2015. PMID: 26700834 Free PMC article. Clinical Trial.
Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial.
Gershlick AH, Khan JN, Kelly DJ, Greenwood JP, Sasikaran T, Curzen N, Blackman DJ, Dalby M, Fairbrother KL, Banya W, Wang D, Flather M, Hetherington SL, Kelion AD, Talwar S, Gunning M, Hall R, Swanton H, McCann GP. Gershlick AH, et al. Among authors: khan jn. J Am Coll Cardiol. 2015 Mar 17;65(10):963-72. doi: 10.1016/j.jacc.2014.12.038. J Am Coll Cardiol. 2015. PMID: 25766941 Free PMC article. Clinical Trial.
Reply: Complete Revascularization in Patients Undergoing Primary Percutaneous Coronary Intervention for STEMI: Is It Really What We Should Be Doing?
Gershlick AH, Khan JN, Kelly DJ, Greenwood JP, Sasikaran T, Curzen N, Blackman DJ, Dalby M, Fairbrother KL, Banya W, Wang D, Flather M, Hetherington SL, Kelion AD, Talwar S, Gunning M, Hall R, Swanton H, McCann GP. Gershlick AH, et al. Among authors: khan jn. J Am Coll Cardiol. 2015 Jul 21;66(3):332-333. doi: 10.1016/j.jacc.2015.04.067. J Am Coll Cardiol. 2015. PMID: 26184630 Free article. No abstract available.
The REFLO-STEMI trial comparing intracoronary adenosine, sodium nitroprusside and standard therapy for the attenuation of infarct size and microvascular obstruction during primary percutaneous coronary intervention: study protocol for a randomised controlled trial.
Nazir SA, Khan JN, Mahmoud IZ, Greenwood JP, Blackman DJ, Kunadian V, Been M, Abrams KR, Wilcox R, Adgey AA, McCann GP, Gershlick AH. Nazir SA, et al. Among authors: khan jn. Trials. 2014 Sep 25;15:371. doi: 10.1186/1745-6215-15-371. Trials. 2014. PMID: 25252600 Free PMC article. Clinical Trial.
The randomised Complete versus Lesion-only PRimary percutaneous coronary Intervention Trial: Cardiovascular Magnetic Resonance imaging substudy (CvLPRIT-CMR).
McCann GP, Khan JN, Greenwood JP, Nazir SA, Dalby M, Curzen N, Hetherington S, Kelly DJ, Blackman DJ, Ring A, Peebles C, Wong J, Sasikaran T, Flather M, Swanton H, Gershlick AH. McCann GP, et al. Among authors: khan jn. Southampton (UK): NIHR Journals Library; 2016 Jan. Southampton (UK): NIHR Journals Library; 2016 Jan. PMID: 26844316 Free Books & Documents. Review.
Strategies to attenuate micro-vascular obstruction during P-PCI: the randomized reperfusion facilitated by local adjunctive therapy in ST-elevation myocardial infarction trial.
Nazir SA, McCann GP, Greenwood JP, Kunadian V, Khan JN, Mahmoud IZ, Blackman DJ, Been M, Abrams KR, Shipley L, Wilcox R, Adgey AA, Gershlick AH. Nazir SA, et al. Among authors: khan jn. Eur Heart J. 2016 Jun 21;37(24):1910-9. doi: 10.1093/eurheartj/ehw136. Epub 2016 May 4. Eur Heart J. 2016. PMID: 27147610 Free PMC article. Clinical Trial.
Infarct Size Following Treatment With Second- Versus Third-Generation P2Y12 Antagonists in Patients With Multivessel Coronary Disease at ST-Segment Elevation Myocardial Infarction in the CvLPRIT Study.
Khan JN, Greenwood JP, Nazir SA, Lai FY, Dalby M, Curzen N, Hetherington S, Kelly DJ, Blackman D, Peebles C, Wong J, Flather M, Swanton H, Gershlick AH, McCann GP. Khan JN, et al. J Am Heart Assoc. 2016 May 31;5(6):e003403. doi: 10.1161/JAHA.116.003403. J Am Heart Assoc. 2016. PMID: 27247336 Free PMC article. Clinical Trial.
Infarct size following complete revascularization in patients presenting with STEMI: a comparison of immediate and staged in-hospital non-infarct related artery PCI subgroups in the CvLPRIT study.
Khan JN, Nazir SA, Greenwood JP, Dalby M, Curzen N, Hetherington S, Kelly DJ, Blackman D, Ring A, Peebles C, Wong J, Sasikaran T, Flather M, Swanton H, Gershlick AH, McCann GP. Khan JN, et al. J Cardiovasc Magn Reson. 2016 Nov 9;18(1):85. doi: 10.1186/s12968-016-0298-2. J Cardiovasc Magn Reson. 2016. PMID: 27842548 Free PMC article. Clinical Trial.
83 results